Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/5575Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Anuradha G. More | - |
| dc.date.accessioned | 2026-07-03T09:27:48Z | - |
| dc.date.available | 2026-07-03T09:27:48Z | - |
| dc.date.issued | 2026-07-03 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/5575 | - |
| dc.description | Vol. 63, No. 5, p 7 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Cervicalcancer | en_US |
| dc.subject | metastatic | en_US |
| dc.subject | EGFR | en_US |
| dc.subject | Epidemal Growth Factor Reseptor | en_US |
| dc.subject | HPV | en_US |
| dc.subject | Human Papillomavirus | en_US |
| dc.subject | VEGF | en_US |
| dc.subject | Vascular Endothelial Growth Factor | en_US |
| dc.subject | Targeted therapy | en_US |
| dc.title | Upcoming strategies for recurrent and methastatic cervical cancer | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol63, No. 5, 2026 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.